Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma

Primary effusion lymphoma (PEL) is an aggressive malignancy with poor prognosis even under chemotherapy. Kaposi sarcoma–associated herpesvirus (KSHV), one of the human oncogenic viruses, is the principal causative agent. Currently, there is no specific treatment for PEL; therefore, developing new th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Chen, Jungang, Goyal, Navneet, Dai, Lu, Lin, Zhen, Del Valle, Luis, Zabaleta, Jovanny, Liu, Jiawang, Post, Steven R., Foroozesh, Maryam, Qin, Zhiqiang
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7645984/
https://ncbi.nlm.nih.gov/pubmed/32518949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005569
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados